This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Sep;68(9):1203-5.

doi: 10.1002/jps.2600680948.

Effect of altered plasma protein binding on apparent volume of distribution

S Oie, T N Tozer

PMID: 501558
DOI: 10.1002/jps.2600680948

Effect of altered plasma protein binding on apparent volume of distribution

S Oie et al. J Pharm Sci. 1979 Sep.

. 1979 Sep;68(9):1203-5.

doi: 10.1002/jps.2600680948.

Authors

S Oie, T N Tozer

PMID: 501558
DOI: 10.1002/jps.2600680948

No abstract available

PubMed Disclaimer

Similar articles

[Plasma binding and pharmacokinetics of drugs].
Tillement JP, Zini R, Glasson S, Jacotot B. Tillement JP, et al. Rev Med Interne. 1982 Mar;3(1):75-80. doi: 10.1016/s0248-8663(82)80011-8. Rev Med Interne. 1982. PMID: 7100698 French. No abstract available.
Drug distribution and binding.
Oie S. Oie S. J Clin Pharmacol. 1986 Nov-Dec;26(8):583-6. doi: 10.1002/j.1552-4604.1986.tb02953.x. J Clin Pharmacol. 1986. PMID: 3793947
Effect of plasma protein binding on clearance of drugs metabolized by Michaelis--Menten kinetics.
Bachmann K, Sullivan TJ. Bachmann K, et al. J Pharm Sci. 1982 Mar;71(3):374-5. doi: 10.1002/jps.2600710334. J Pharm Sci. 1982. PMID: 7069607 No abstract available.
Plasma protein binding and therapeutic drug monitoring.
Rowland M. Rowland M. Ther Drug Monit. 1980;2(1):29-37. doi: 10.1097/00007691-198001000-00005. Ther Drug Monit. 1980. PMID: 6762701 Review. No abstract available.
Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
Tillement JP, Albengres E, Urien S. Tillement JP, et al. Eur J Drug Metab Pharmacokinet. 1979;4(3):123-7. doi: 10.1007/BF03189413. Eur J Drug Metab Pharmacokinet. 1979. PMID: 393513 Review.

See all similar articles

Cited by

M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier.
Machl A, Wilker EW, Tian H, Liu X, Schroeder P, Clark A, Huck BR. Machl A, et al. Am J Cancer Res. 2016 Mar 15;6(4):806-18. eCollection 2016. Am J Cancer Res. 2016. PMID: 27186432 Free PMC article.
Pharmacokinetics of individual components of teicoplanin in man.
Bernareggi A, Danese A, Cometti A, Buniva G, Rowland M. Bernareggi A, et al. J Pharmacokinet Biopharm. 1990 Dec;18(6):525-43. doi: 10.1007/BF01073937. J Pharmacokinet Biopharm. 1990. PMID: 2149149
Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.
Trenk D, Winkelmann B, Jähnchen E, Oie S. Trenk D, et al. J Pharmacokinet Biopharm. 1988 Feb;16(1):1-12. doi: 10.1007/BF01061859. J Pharmacokinet Biopharm. 1988. PMID: 3373415
Metabolic disposition of DQ-2556, a new cephalosporin, in rats, rabbits, dogs, and monkeys.
Matsubayashi K, Shintani S, Yoshioka M, Tachizawa H. Matsubayashi K, et al. Antimicrob Agents Chemother. 1992 May;36(5):966-72. doi: 10.1128/AAC.36.5.966. Antimicrob Agents Chemother. 1992. PMID: 1510421 Free PMC article.
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans.
Kim MS, Song YK, Choi JS, Ji HY, Yang E, Park JS, Kim HS, Kim MJ, Cho IK, Chung SJ, Chae YJ, Lee KR. Kim MS, et al. Pharmaceutics. 2023 Mar 14;15(3):942. doi: 10.3390/pharmaceutics15030942. Pharmaceutics. 2023. PMID: 36986803 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Wiley